Funding for this research was provided by:
National Institute on Drug Abuse (R33 DA035640, UG1 DA015815)
Received: 26 January 2019
Accepted: 8 August 2019
First Online: 15 August 2019
Ethics approval and consent to participate
: The Oregon Health & Science University’s Institutional Review Board reviewed the study protocol, qualitative interview guides, and information sheet (interview data were not included in this manuscript).
: Not applicable.
: Dr. McCarty served as an investigator on clinical trials using donated medications from Alkermes. All other authors declare that they have no competing interests.